Cited by 783Blood Pressure and Hypertension StudiesSodium Intake and HealthCardiovascular Health and Disease Prevention

The DOI matches its Crossref record, with a small difference in title or year; 32 of the 33 references it cites were found in a registry or an index.

Systolic Blood Pressure Reduction and Risk of Cardiovascular Disease and Mortality: A Systematic Review and Network Meta-analysis

Open access

Bundy, Joshua D., Li, Changwei, Stuchlik, Patrick, Bu, Xiaoqing, Kelly, Tanika N., Mills, Katherine T., He, Hua, Chen, Jing, Whelton, Paul K., He, Jiang·2017·JAMA Cardiology

DOI 10.1001/jamacardio.2017.1421PMC PMC5710614

Open this paper in CoChat — free account Open PDF

Abstract

Importance: Clinical trials have documented that lowering blood pressure reduces cardiovascular disease and premature deaths. However, the optimal target for reduction of systolic blood pressure (SBP) is uncertain. Objective: To assess the association of mean achieved SBP levels with the risk of cardiovascular disease and all-cause mortality in adults with hypertension treated with antihypertensive therapy. Data Sources: MEDLINE and EMBASE were searched from inception to December 15, 2015, supplemented by manual searches of the bibliographies of retrieved articles. Study Selection: Studies included were clinical trials with random allocation to an antihypertensive medication, control, or treatment target. Studies had to have reported a difference in mean achieved SBP of 5 mm Hg or more between comparison groups. Data Extraction and Synthesis: Data were extracted from each study independently and in duplicate by at least 2 investigators according to a standardized protocol. Network meta-analysis was used to obtain pooled randomized results comparing the association of each 5-mm Hg SBP category with clinical outcomes after adjusting for baseline risk. Main Outcomes and Measures: Cardiovascular disease and all-cause mortality. Results: Forty-two trials, including 144 220 patients, met the eligibility criteria. In general, there were linear associations between mean achieved SBP and risk of cardiovascular disease and mortality, with the lowest risk at 120 to 124 mm Hg. Randomized groups with a mean achieved SBP of 120 to 124 mm Hg had a hazard ratio (HR) for major cardiovascular disease of 0.71 (95% CI, 0.60-0.83) compared with randomized groups with a mean achieved SBP of 130 to 134 mm Hg, an HR of 0.58 (95% CI, 0.48-0.72) compared with those with a mean achieved SBP of 140 to 144 mm Hg, an HR of 0.46 (95% CI, 0.34-0.63) compared with those with a mean achieved SBP of 150 to 154 mm Hg, and an HR of 0.36 (95% CI, 0.26-0.51) compared with those with a mean achieved SBP of 160 mm Hg or more. Likewise, randomized groups with a mean achieved SBP of 120 to 124 mm Hg had an HR for all-cause mortality of 0.73 (95% CI, 0.58-0.93) compared with randomized groups with a mean achieved SBP of 130 to 134 mm Hg, an HR of 0.59 (95% CI, 0.45-0.77) compared with those with a mean achieved SBP of 140 to 144 mm Hg, an HR of 0.51 (95% CI, 0.36-0.71) compared with those with a mean achieved SBP of 150 to 154 mm Hg, and an HR of 0.47 (95% CI, 0.32-0.67) compared with those with a mean achieved SBP of 160 mm Hg or more. Conclusions and Relevance: This study suggests that reducing SBP to levels below currently recommended targets significantly reduces the risk of cardiovascular disease and all-cause mortality. These findings support more intensive control of SBP among adults with hypertension.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1001/jamacardio.2017.1421

Cites

32 of 32 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The Cochrane Collaboration's tool for assessing risk of bias in randomised trials
Higgins, J. P. T., Altman, D. G., Gotzsche, P. C., Juni, P., Moher, D., Oxman, A. D., Savovic, J., Schulz, K. F., Weeks, L., Sterne, J. A. C., et al. (2011) · BMJ · doi:10.1136/bmj.d5928 · Cited by 33,817
Magnesium Replacement Improves the Metabolic Profile in Obese and Pre-Diabetic Patients with Mild-to-Moderate Chronic Kidney Disease: A 3-Month, Randomised, Double-Blind, Placebo-Controlled Study
Toprak, Ö., Kurt, H., Sarı, Y., Şarkış, C., Us, H., & Kırık, A. (2017) · Kidney & Blood Pressure Research · doi:10.1159/000468530 · Cited by 29,772
The “Golden Age” of Probiotics: A Systematic Review and Meta-Analysis of Randomized and Observational Studies in Preterm Infants
Dermyshi, E., Wang, Y., Yan, C., Hong, W., Qiu, G., Gong, X., & Zhang, T. (2017) · Neonatology · doi:10.1159/000454668 · Cited by 24,586
Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
Chobanian, A. V., Bakris, G. L., Black, H. R., Cushman, W. C., Green, L. A., Izzo, J. L., Jones, D. W., Materson, B. J., Oparil, S., Wright, J. T., et al. (2003) · Hypertension · doi:10.1161/01.hyp.0000107251.49515.c2 · Cited by 13,271
Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies
(2002) · The Lancet · doi:10.1016/s0140-6736(02)11911-8 · Cited by 10,266
Global burden of hypertension: analysis of worldwide data
Kearney, P. M., Whelton, M., Reynolds, K., Muntner, P., Whelton, P. K., & He, J. (2005) · The Lancet · doi:10.1016/s0140-6736(05)17741-1 · Cited by 8,698
Self-citation
2014 Evidence-Based Guideline for the Management of High Blood Pressure in Adults: Report From the Panel Members Appointed to the Eighth Joint National Committee (JNC 8)
James, P. A., Oparil, S., Carter, B. L., Cushman, W. C., Dennison-Himmelfarb, C., Handler, J., Lackland, D. T., LeFevre, M. L., MacKenzie, T. D., Ogedegbe, O., et al. (2014) · JAMA · doi:10.1001/jama.2013.284427 · Cited by 7,950
Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013
(2015) · The Lancet · doi:10.1016/s0140-6736(14)61682-2 · Cited by 7,439
A Randomized Trial of Intensive versus Standard Blood-Pressure Control
The SPRINT Research Group (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1511939 · Cited by 6,325
Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis
Ettehad, D., Emdin, C. A., Kiran, A., Anderson, S. G., Callender, T., Emberson, J., Chalmers, J., Rodgers, A., & Rahimi, K. (2016) · The Lancet · doi:10.1016/s0140-6736(15)01225-8 · Cited by 3,755

Show all 33 references

Research works printed but not linked: 1

[17]17. Jones DW, Weatherly L, Hall JE. SPRINT: what remains unanswered and where do we go from here? Hypertension. 2016;67(2):261-262.

Sorted by citations

Heart Disease and Stroke Statistics—2020 Update: A Report From the American Heart Association
Virani, S. S., Alonso, A., Benjamin, E. J., Bittencourt, M. S., Callaway, C. W., Carson, A. P., Chamberlain, A. M., Chang, A. R., Cheng, S., Delling, F. N., et al. (2020) · Circulation · doi:10.1161/cir.0000000000000757 · Cited by 9,175
Heart Disease and Stroke Statistics—2019 Update: A Report From the American Heart Association
Benjamin, E. J., Muntner, P., Alonso, A., Bittencourt, M. S., Callaway, C. W., Carson, A. P., Chamberlain, A. M., Chang, A. R., Cheng, S., Das, S. R., et al. (2019) · Circulation · doi:10.1161/cir.0000000000000659 · Cited by 9,036
2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
Whelton, P. K., Carey, R. M., Aronow, W. S., Casey, D. E., Collins, K. J., Dennison Himmelfarb, C., DePalma, S. M., Gidding, S., Jamerson, K. A., Jones, D. W., et al. (2018) · Hypertension · doi:10.1161/hyp.0000000000000065 · Cited by 7,391
Self-citation
2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults
Whelton, P. K., Carey, R. M., Aronow, W. S., Casey, D. E., Collins, K. J., Dennison Himmelfarb, C., DePalma, S. M., Gidding, S., Jamerson, K. A., Jones, D. W., et al. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.11.006 · Cited by 6,616
Self-citation
Heart Disease and Stroke Statistics—2023 Update: A Report From the American Heart Association
Tsao, C. W., Aday, A. W., Almarzooq, Z. I., Anderson, C. A. M., Arora, P., Avery, C. L., Baker-Smith, C. M., Beaton, A. Z., Boehme, A. K., Buxton, A. E., et al. (2023) · Circulation · doi:10.1161/cir.0000000000001123 · Cited by 8,300
Heart Disease and Stroke Statistics—2022 Update: A Report From the American Heart Association
Tsao, C. W., Aday, A. W., Almarzooq, Z. I., Alonso, A., Beaton, A. Z., Bittencourt, M. S., Boehme, A. K., Buxton, A. E., Carson, A. P., Commodore-Mensah, Y., et al. (2022) · Circulation · doi:10.1161/cir.0000000000001052 · Cited by 5,987
Heart Disease and Stroke Statistics—2021 Update: A Report From the American Heart Association
Virani, S. S., Alonso, A., Aparicio, H. J., Benjamin, E. J., Bittencourt, M. S., Callaway, C. W., Carson, A. P., Chamberlain, A. M., Cheng, S., Delling, F. N., et al. (2021) · Circulation · doi:10.1161/cir.0000000000000950 · Cited by 5,784
2019 ACC/AHA guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.
Arnett, D. K., Blumenthal, R. S., Albert, M. A., Buroker, A. B., Goldberger, Z. D., Hahn, E. J., Himmelfarb, C. D., Khera, A., Lloyd-Jones, D., McEvoy, J. W., et al. (2019) · Circulation · doi:10.1161/cir.0000000000000678 · Cited by 4,536
2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
Whelton, P. K., Carey, R. M., Aronow, W. S., Casey, D. E., Collins, K. J., Dennison Himmelfarb, C., DePalma, S. M., Gidding, S., Jamerson, K. A., Jones, D. W., et al. (2018) · Hypertension · doi:10.1161/hyp.0000000000000066 · Cited by 4,347
Self-citation
The global epidemiology of hypertension
Mills, K. T., Stefanescu, A. R., & He, J. (2020) · Nature Reviews Nephrology · doi:10.1038/s41581-019-0244-2 · Cited by 4,777
Self-citation
2024 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association
Martin, S. S., Aday, A. W., Almarzooq, Z. I., Anderson, C. A. M., Arora, P., Avery, C. L., Baker-Smith, C. M., Barone Gibbs, B., Beaton, A. Z., Boehme, A. K., et al. (2024) · Circulation · doi:10.1161/cir.0000000000001209 · Cited by 2,800
High blood pressure and cardiovascular disease
Fuchs, F. D., & Whelton, P. K. (2020) · Hypertension · doi:10.1161/hypertensionaha.119.14240 · Cited by 1,948
Self-citation
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease
Arnett, D. K., Blumenthal, R. S., Albert, M. A., Buroker, A. B., Goldberger, Z. D., Hahn, E. J., Himmelfarb, C. D., Khera, A., Lloyd-Jones, D., McEvoy, J. W., et al. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.03.010 · Cited by 1,896
The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2019)
Umemura, S., Arima, H., Arima, S., Asayama, K., Dohi, Y., Hirooka, Y., Horio, T., Hoshide, S., Ikeda, S., Ishimitsu, T., et al. (2019) · Hypertension Research · doi:10.1038/s41440-019-0284-9 · Cited by 1,880
2023 AHA/ACC/ACCP/ASPC/NLA/PCNA guideline for the management of patients with chronic coronary disease: a report of the American Heart Association/American College of Cardiology joint committee on clinical practice guidelines
Virani, S. S., Newby, L. K., Arnold, S. V., Bittner, V., Brewer, L. C., Demeter, S. H., Dixon, D. L., Fearon, W. F., Hess, B., Johnson, H. M., et al. (2023) · Circulation · doi:10.1161/cir.0000000000001168 · Cited by 1,598
Global epidemiology, health burden and effective interventions for elevated blood pressure and hypertension
Zhou, B., Perel, P., Mensah, G. A., & Ezzati, M. (2021) · Nature Reviews Cardiology · doi:10.1038/s41569-021-00559-8 · Cited by 1,694
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary
Arnett, D. K., Blumenthal, R. S., Albert, M. A., Buroker, A. B., Goldberger, Z. D., Hahn, E. J., Himmelfarb, C. D., Khera, A., Lloyd-Jones, D., McEvoy, J. W., et al. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.03.009 · Cited by 1,193
2025 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association
Martin, S. S., Aday, A. W., Allen, N. B., Almarzooq, Z., Anderson, C. A. M., Arora, P. K., Avery, C. L., Baker-Smith, C. M., Bansal, N., Beaton, A., et al. (2025) · Circulation · doi:10.1161/cir.0000000000001303 · Cited by 1,284
2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
Whelton, P. K., Carey, R. M., Aronow, W. S., Casey, D. E., Collins, K. J., Dennison Himmelfarb, C., DePalma, S. M., Gidding, S., Jamerson, K. A., Jones, D. W., et al. (2018) · Circulation · doi:10.1161/cir.0000000000000596 · Cited by 1,127
Self-citation
Diretrizes Brasileiras de Hipertensão Arterial – 2020
Barroso, W. K. S., Rodrigues, C. I. S., Bortolotto, L. A., Gomes, M. A. M., Brandão, A. A., Feitosa, A. D. M., Machado, C. A., Poli‐de‐Figueiredo, C. E., Amodeo, C., Mion, D., et al. (2021) · Arquivos Brasileiros de Cardiologia · doi:10.36660/abc.20201238 · Cited by 1,389
2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
Whelton, P. K., Carey, R. M., Aronow, W. S., Casey, D. E., Collins, K. J., Himmelfarb, C. D., DePalma, S. M., Gidding, S. S., Jamerson, K., Jones, D. W., et al. (2018) · Circulation · doi:10.1161/cir.0000000000000597 · Cited by 1,005
Self-citation
Trends in Blood Pressure Control Among US Adults With Hypertension, 1999-2000 to 2017-2018
Muntner, P., Hardy, S. T., Fine, L. J., Jaeger, B. C., Wozniak, G. D., Levitan, E. B., & Colantonio, L. D. (2020) · JAMA · doi:10.1001/jama.2020.14545 · Cited by 967
2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Executive Summary
Whelton, P. K., Carey, R. M., Aronow, W. S., Casey, D. E., Collins, K. J., Himmelfarb, C. D., DePalma, S. M., Gidding, S. S., Jamerson, K., Jones, D. W., et al. (2018) · Journal of the American Society of Hypertension · doi:10.1016/j.jash.2018.06.010 · Cited by 948
Self-citation
Potential US Population Impact of the 2017 ACC/AHA High Blood Pressure Guideline
Muntner, P., Carey, R. M., Gidding, S. S., Jones, D. W., Taler, S. J., Wright, J. T., & Whelton, P. K. (2017) · Circulation · doi:10.1161/circulationaha.117.032582 · Cited by 963
“participants), the risk for CVD mortality was lowest with SBP levels between 120 and 124 mm Hg (23).”
Self-citation
2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Executive Summary
Whelton, P. K., Carey, R. M., Aronow, W. S., Casey, D. E., Collins, K. J., Himmelfarb, C. D., DePalma, S. M., Gidding, S. S., Jamerson, K., Jones, D. W., et al. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.11.005 · Cited by 947
“Higher SBP has consistently been associated with increased CVD risk after adjustment for, or within strata of, DBP (3-5).”
InfluentialSelf-citation
KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease
Cheung, A. K., Chang, T. I., Cushman, W. C., Furth, S. L., Hou, F. F., Ix, J. H., Knoll, G. A., Muntner, P., Pecoits-Filho, R., Sarnak, M. J., et al. (2021) · Kidney International · doi:10.1016/j.kint.2020.11.003 · Cited by 1,452
Effect of renal denervation on blood pressure in the presence of antihypertensive drugs: 6-month efficacy and safety results from the SPYRAL HTN-ON MED proof-of-concept randomised trial
Kandzari, D. E., Böhm, M., Mahfoud, F., Townsend, R. R., Weber, M. A., Pocock, S., Tsioufis, K., Tousoulis, D., Choi, J. W., East, C., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)30951-6 · Cited by 793
Catheter-based renal denervation in patients with uncontrolled hypertension in the absence of antihypertensive medications (SPYRAL HTN-OFF MED): a randomised, sham-controlled, proof-of-concept trial
Townsend, R. R., Mahfoud, F., Kandzari, D. E., Kario, K., Pocock, S., Weber, M. A., Ewen, S., Tsioufis, K., Tousoulis, D., Sharp, A. S. P., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)32281-x · Cited by 752
Heterogeneous aging across multiple organ systems and prediction of chronic disease and mortality
Tian, Y. E., Cropley, V., Maier, A. B., Lautenschlager, N. T., Breakspear, M., & Zalesky, A. (2023) · Nature Medicine · doi:10.1038/s41591-023-02296-6 · Cited by 618
2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease
Virani, S. S., Newby, L. K., Arnold, S. V., Bittner, V., Brewer, L. C., Demeter, S. H., Dixon, D. L., Fearon, W. F., Hess, B., Johnson, H. M., et al. (2023) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2023.04.003 · Cited by 596
Trends in Prevalence of Diabetes and Control of Risk Factors in Diabetes Among US Adults, 1999-2018
Wang, L., Li, X., Wang, Z., Bancks, M. P., Carnethon, M. R., Greenland, P., Feng, Y., Wang, H., & Zhong, V. W. (2021) · JAMA · doi:10.1001/jama.2021.9883 · Cited by 587
Untitled work
(2019) · doi:10.1161/cir.0000000000000677 · Cited by 4,501
Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Synopsis of the 2017 American College of Cardiology/American Heart Association Hypertension Guideline
Carey, R. M., & Whelton, P. K. (2018) · Annals of Internal Medicine · doi:10.7326/m17-3203 · Cited by 554
“Stage 2 hypertension is defined as an average SBP of at least 140 mm Hg or an average DBP of at least 90 mm Hg instead of a BP of at least 160/100 mm Hg.”
BackgroundResultInfluentialSelf-citation
Association of Blood Pressure Lowering With Mortality and Cardiovascular Disease Across Blood Pressure Levels
Brunström, M., & Carlberg, B. (2017) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2017.6015 · Cited by 483
Primary prevention of cardiovascular disease: A review of contemporary guidance and literature
Stewart, J., Manmathan, G. P. R., & Wilkinson, P. (2017) · JRSM Cardiovascular Disease · doi:10.1177/2048004016687211 · Cited by 516
Treatment of hypertension: a review
Carey, R. M., Moran, A. E., & Whelton, P. K. (2022) · JAMA · doi:10.1001/jama.2022.19590 · Cited by 455
Self-citation
Periodontitis is associated with hypertension: a systematic review and meta-analysis
Muñoz Aguilera, E., Suvan, J., Buti, J., Czesnikiewicz-Guzik, M., Barbosa Ribeiro, A., Orlandi, M., Guzik, T. J., Hingorani, A. D., Nart, J., & D’Aiuto, F. (2020) · Cardiovascular Research · doi:10.1093/cvr/cvz201 · Cited by 394
“Blood pressure values are an important predictor of cardiovascular risk (5, 6).”
Background
2024 Guideline for the Primary Prevention of Stroke: A Guideline From the American Heart Association/American Stroke Association
Bushnell, C., Kernan, W. N., Sharrief, A. Z., Chaturvedi, S., Cole, J. W., Cornwell, W. K., Cosby-Gaither, C., Doyle, S., Goldstein, L. B., Lennon, O. C., et al. (2024) · Stroke · doi:10.1161/str.0000000000000475 · Cited by 443
Self-citation
Medication adherence and blood pressure control: a scientific statement from the American Heart Association
Choudhry, N. K., Kronish, I. M., Vongpatanasin, W., Ferdinand, K. C., Pavlik, V. N., Egan, B. M., Schoenthaler, A., Houston Miller, N., Hyman, D. J., & on behalf of the American Heart Association Council on Hypertension; Council on Cardiovascular and Stroke Nursing; and Council on Clinical Cardiology (2022) · Hypertension · doi:10.1161/hyp.0000000000000203 · Cited by 349
Diabetic Kidney Disease
Gupta, S., Dominguez, M., & Golestaneh, L. (2023) · Medical Clinics of North America · doi:10.1016/j.mcna.2023.03.004 · Cited by 373
Potential U.S. Population Impact of the 2017 ACC/AHA High Blood Pressure Guideline
Muntner, P., Carey, R. M., Gidding, S., Jones, D. W., Taler, S. J., Wright, J. T., & Whelton, P. K. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.10.073 · Cited by 339
“and 124 mmHg.(23) Although some adults will benefit from treatment to lower BP levels, the 2017 by gest on D ecem er (2)3, 2017 http://ciajournals.”
Self-citation
2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
Jones, D. W., Ferdinand, K. C., Taler, S. J., Johnson, H. M., Shimbo, D., Abdalla, M., Altieri, M. M., Bansal, N., Bello, N. A., Bress, A. P., et al. (2025) · Hypertension · doi:10.1161/hyp.0000000000000249 · Cited by 424
Self-citation
Hypertension and Stroke: Update on Treatment
Wajngarten, M., & Silva, G. S. (2019) · European Cardiology Review · doi:10.15420/ecr.2019.11.1 · Cited by 305
Clinical management of stable coronary artery disease in patients with type 2 diabetes mellitus: a scientific statement from the American Heart Association
Arnold, S. V., Bhatt, D. L., Barsness, G. W., Beatty, A. L., Deedwania, P. C., Inzucchi, S. E., Kosiborod, M., Leiter, L. A., Lipska, K. J., Newman, J. D., et al. (2020) · Circulation · doi:10.1161/cir.0000000000000766 · Cited by 304
Effects of High-Intensity Interval Training Versus Moderate-Intensity Continuous Training On Blood Pressure in Adults with Pre- to Established Hypertension: A Systematic Review and Meta-Analysis of Randomized Trials
Costa, E. C., Hay, J. L., Kehler, D. S., Boreskie, K. F., Arora, R. C., Umpierre, D., Szwajcer, A., & Duhamel, T. A. (2018) · Sports Medicine · doi:10.1007/s40279-018-0944-y · Cited by 281
Cost-Effectiveness of Intensive versus Standard Blood-Pressure Control
Bress, A. P., Bellows, B. K., King, J. B., Hess, R., Beddhu, S., Zhang, Z., Berlowitz, D. R., Conroy, M. B., Fine, L. J., Oparil, S., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmsa1616035 · Cited by 289
Trends in Prevalence and Control of Hypertension According to the 2017 American College of Cardiology/American Heart Association (ACC/AHA) Guideline
DORANS, K. S., Mills, K. T., Liu, Y., & He, J. (2018) · Journal of the American Heart Association · doi:10.1161/jaha.118.008888 · Cited by 297
“A network meta-analysis of randomized clinical trials reported positive linear relationships between mean achieved systolic BP and risk of CVD and all-cause mortality; lowest risks were observed among those with achieved systolic BP of 120 to 124 mm Hg.8 The 2017 American College of Cardiology/American Heart Associati…”
BackgroundInfluentialSelf-citation
Exercise training and resting blood pressure: a large-scale pairwise and network meta-analysis of randomised controlled trials
Edwards, J. J., Deenmamode, A. H. P., Griffiths, M., Arnold, O., Cooper, N. J., Wiles, J. D., & O'Driscoll, J. M. (2023) · British Journal of Sports Medicine · doi:10.1136/bjsports-2022-106503 · Cited by 284
2026 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association
Palaniappan, L. P., Allen, N. B., Almarzooq, Z., Anderson, C. A. M., Arora, P. K., Avery, C. L., Baker-Smith, C. M., Bansal, N., Currie, M. E., Earlie, R. S., et al. (2026) · Circulation · doi:10.1161/cir.0000000000001412 · Cited by 343
Evaluation of phytochemical and medicinal properties of Moringa (Moringa oleifera) as a potential functional food
Ma, Z. F., Ahmad, J., Zhang, H., Khan, I. A., & Muhammad, S. (2019) · South African Journal of Botany · doi:10.1016/j.sajb.2018.12.002 · Cited by 258
Hypertensive Disorders of Pregnancy and Future Maternal Cardiovascular Risk
Ying, W., Catov, J. M., & Ouyang, P. (2018) · Journal of the American Heart Association · doi:10.1161/jaha.118.009382 · Cited by 262
2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults
Jones, D. W., Ferdinand, K. C., Taler, S. J., Johnson, H. M., Shimbo, D., Abdalla, M., Altieri, M. M., Bansal, N., Bello, N. A., Bress, A. P., et al. (2025) · JACC · doi:10.1016/j.jacc.2025.05.007 · Cited by 280
Self-citation
2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
Jones, D. W., Ferdinand, K. C., Taler, S. J., Johnson, H. M., Shimbo, D., Abdalla, M., Altieri, M. M., Bansal, N., Bello, N. A., Bress, A. P., et al. (2025) · Circulation · doi:10.1161/cir.0000000000001356 · Cited by 335
Self-citation
Hypertension management in patients with cardiovascular comorbidities
Lauder, L., Mahfoud, F., Azizi, M., Bhatt, D. L., Ewen, S., Kario, K., Parati, G., Rossignol, P., Schlaich, M. P., Teo, K. K., et al. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehac395 · Cited by 232
Hypertension as a risk factor for atherosclerosis: Cardiovascular risk assessment
Poznyak, A. V., Sadykhov, N. K., Kartuesov, A. G., Borisov, E. E., Melnichenko, A. А., Grechko, A. V., & Orekhov, A. N. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.959285 · Cited by 229
The global burden of hypertension exceeds 1.4 billion people
Egan, B. M., Kjeldsen, S. E., Grassi, G. M., Esler, M., & Mancia, G. (2019) · Journal of Hypertension · doi:10.1097/hjh.0000000000002021 · Cited by 207
“Among adults who were treated and controlled, the mean SBP was approximately 121, which is within the optimal range of 120–124 [11].”
Background
Impact of 2017 ACC/AHA guidelines on prevalence of hypertension and eligibility for antihypertensive treatment in United States and China: nationally representative cross sectional study
Khera, R., Lu, Y., Lu, J., Saxena, A., Nasir, K., Jiang, L., & Krumholz, H. M. (2018) · BMJ · doi:10.1136/bmj.k2357 · Cited by 196
Guideline-Driven Management of Hypertension
Carey, R. M., Wright, J. T., Taler, S. J., & Whelton, P. K. (2021) · Circulation Research · doi:10.1161/circresaha.121.318083 · Cited by 224
Self-citation
Blood Pressure Control Among US Adults, 2009 to 2012 Through 2017 to 2020
Muntner, P., Miles, M. A., Jaeger, B. C., Hannon, L., Hardy, S. T., Ostchega, Y., Wozniak, G. D., & Schwartz, J. E. (2022) · Hypertension · doi:10.1161/hypertensionaha.122.19222 · Cited by 186
“Three goals were outlined in the Call-to-Action: (1) making hypertension a national priority; (2) ensuring the places where people live, learn, work, and play support hypertension control; and (3) optimizing patient care for hypertension control.”
Background
Renal denervation in the management of hypertension in adults. A clinical consensus statement of the ESC Council on Hypertension and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)
Barbato, E., Azizi, M., Schmieder, R. E., Lauder, L., Böhm, M., Brouwers, S., Bruno, R. M., Dudek, D., Kahan, T., Kandzari, D. E., et al. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehad054 · Cited by 188
“Lowering BP through the use of antihypertensive drugs has been shown to reduce the risk for CV morbidity and all-cause mortality 3,4 .”
A village doctor-led multifaceted intervention for blood pressure control in rural China: an open, cluster randomised trial
Sun, Y., Mu, J., Wang, D. W., Ouyang, N., Xing, L., Guo, X., Zhao, C., Ren, G., Ye, N., Zhou, Y., et al. (2022) · The Lancet · doi:10.1016/s0140-6736(22)00325-7 · Cited by 179
Self-citation
The 2022 focused update of the 2018 Korean Hypertension Society Guidelines for the management of hypertension
Kim, H., Lee, E. M., Ahn, S. Y., Kim, K., Kim, H. C., Kim, J. H., Lee, H., Lee, J. H., Park, J., Cho, E. J., et al. (2023) · Clinical Hypertension · doi:10.1186/s40885-023-00234-9 · Cited by 168
Effectiveness of a non-physician community health-care provider-led intensive blood pressure intervention versus usual care on cardiovascular disease (CRHCP): an open-label, blinded-endpoint, cluster-randomised trial
He, J., Ouyang, N., Guo, X., Sun, G., Li, Z., Mu, J., Wang, D. W., Qiao, L., Xing, L., Ren, G., et al. (2023) · The Lancet · doi:10.1016/s0140-6736(22)02603-4 · Cited by 160
Self-citation
Supervised lifestyle intervention for people with metabolic syndrome improves outcomes and reduces individual risk factors of metabolic syndrome: A systematic review and meta-analysis
van Namen, M., Prendergast, L. A., & Peiris, C. L. (2019) · Metabolism · doi:10.1016/j.metabol.2019.153988 · Cited by 143
Effect of Exercise Training on Ambulatory Blood Pressure Among Patients With Resistant Hypertension
Lopes, S., Bastos, J. M., Garcia, C., Bertoquini, S., Ribau, V., Teixeira, M., Ribeiro, I. P., Melo, J. B., de Oliveira, J. J. F., de Figueiredo, D. M. P., et al. (2021) · JAMA Cardiology · doi:10.1001/jamacardio.2021.2735 · Cited by 158
Effects of school-based high-intensity interval training on body composition, cardiorespiratory fitness and cardiometabolic markers in adolescent boys with obesity: a randomized controlled trial
Cao, M., Tang, Y., Shu, L., & Zou, Y. (2022) · BMC Pediatrics · doi:10.1186/s12887-021-03079-z · Cited by 128
“Development of obesity increases the likelihood of hypertension in childhood leading to future hypertension [45].”
Background
Recent Advances in the Management of Autosomal Dominant Polycystic Kidney Disease
Chebib, F. T., & Torres, V. E. (2018) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.03960318 · Cited by 128
“Recent meta-analyses of clinical trials have supported the SPRINT results (14,15).”
Result
Screening for Hypertension in Adults
Guirguis‐Blake, J., Evans, C. V., Webber, E. M., Coppola, E. L., Perdue, L. A., & Weyrich, M. S. (2021) · JAMA · doi:10.1001/jama.2020.21669 · Cited by 129
Effects of Intensive Systolic Blood Pressure Lowering on Cardiovascular Events and Mortality in Patients With Type 2 Diabetes Mellitus on Standard Glycemic Control and in Those Without Diabetes Mellitus: Reconciling Results From ACCORD BP and SPRINT
Beddhu, S., Chertow, G. M., Greene, T., Whelton, P. K., Ambrosius, W. T., Cheung, A. K., Cutler, J. A., Fine, L. J., Boucher, R. E., Wei, G., et al. (2018) · Journal of the American Heart Association · doi:10.1161/jaha.118.009326 · Cited by 116
Self-citation
Sustainable solutions to mitigate occupational heat strain – an umbrella review of physiological effects and global health perspectives
Morris, N. B., Jay, O., Flouris, A. D., Casanueva, A., Gao, C., Foster, J., Havenith, G., & Nybo, L. (2020) · Environmental Health · doi:10.1186/s12940-020-00641-7 · Cited by 121
Effects of elevated systolic blood pressure on ischemic heart disease: a Burden of Proof study
Razo, C., Welgan, C. A., Johnson, C. O., McLaughlin, S. A., Iannucci, V. C., Rodgers, A., Wang, N., LeGrand, K. E., Sorensen, R. J. D., He, J., et al. (2022) · Nature Medicine · doi:10.1038/s41591-022-01974-1 · Cited by 116
Self-citation
The Effect of Alcohol on Blood Pressure and Hypertension
Fuchs, F. D., & Fuchs, S. C. P. C. (2021) · Current Hypertension Reports · doi:10.1007/s11906-021-01160-7 · Cited by 116
Estimating the Association of the 2017 and 2014 Hypertension Guidelines With Cardiovascular Events and Deaths in US Adults
Bundy, J. D., Mills, K. T., Chen, J., Li, C., Greenland, P., & He, J. (2018) · JAMA Cardiology · doi:10.1001/jamacardio.2018.1240 · Cited by 109
Self-citation
2019 AHA/ACC Clinical Performance and Quality Measures for Adults With High Blood Pressure: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures
Casey, D. E., Thomas, R. J., Bhalla, V., Commodore-Mensah, Y. Y., Heidenreich, P. A., Kolte, D. S., Muntner, P., Smith, S. C., Spertus, J. A., Windle, J. R., et al. (2019) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/hcq.0000000000000057 · Cited by 102
Renal Denervation for the Treatment of Hypertension: A Scientific Statement From the American Heart Association
Cluett, J., Blazek, O., Brown, A. L., East, C. A., Ferdinand, K. C., Fisher, N. D. L., Ford, C. D., Griffin, K. A., Mena‐Hurtado, C., Sarathy, H., et al. (2024) · Hypertension · doi:10.1161/hyp.0000000000000240 · Cited by 110
“65,66 With RDN, office and ambulatory SBP decreases of 5 to 10 mm Hg are often achieved and thus could be expected to have a similar risk reduction, 67,68 but further research in this area is needed.”
The Effects of a Short Forest Recreation Program on Physiological and Psychological Relaxation in Young Polish Adults
Bielinis, E., Bielinis, L., Krupińska-Szeluga, S., Łukowski, A., & Takayama, N. (2019) · Forests · doi:10.3390/f10010034 · Cited by 100
“Higher SBP is linked with cardiovascular disease and mortality, making every method that effectively lowers SBP valuable to overall human health [49].”
Background
Does four-week consecutive, dawn-to-sunset intermittent fasting during Ramadan affect cardiometabolic risk factors in healthy adults? A systematic review, meta-analysis, and meta-regression
Jahrami, H., Faris, M. E., Janahi, A. I., Janahi, M. I., Abdelrahim, D. N., Madkour, M. I., Sater, M. S., Hassan, A. B., & Bahammam, A. S. (2021) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2021.05.002 · Cited by 97
A major mechanism for immunomodulation: Dietary fibres and acid metabolites
Xie, L., Alam, J., Marques, F. Z., & Mackay, C. R. (2023) · Seminars in Immunology · doi:10.1016/j.smim.2023.101737 · Cited by 101
2017 ACC/AHA Blood Pressure Treatment Guideline Recommendations and Cardiovascular Risk
Colantonio, L. D., Booth, J. N., Bress, A. P., Whelton, P. K., Shimbo, D., Levitan, E. B., Howard, G., Safford, M. M., & Muntner, P. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.05.074 · Cited by 99
Self-citation
Epidemiology of hypertension in Japan: beyond the new 2019 Japanese guidelines
Hisamatsu, T., Segawa, H., Kadota, A., Ohkubo, T., Arima, H., & Miura, K. (2020) · Hypertension Research · doi:10.1038/s41440-020-0508-z · Cited by 102
JCS 2018 Guideline on Diagnosis of Chronic Coronary Heart Diseases
Yamagishi, M., Tamaki, N., Akasaka, T., Ikeda, T., Ueshima, K., Uemura, S., Otsuji, Y., Kihara, Y., Kimura, K., Kimura, T., et al. (2021) · Circulation Journal · doi:10.1253/circj.cj-19-1131 · Cited by 100
International Consensus on Standardized Clinic Blood Pressure Measurement – A Call to Action
Cheung, A. K., Whelton, P. K., Muntner, P., Schutte, A. E., Moran, A. E., Williams, B., Sarafidis, P., Chang, T. I., Daskalopoulou, S. S., Flack, J. M., et al. (2023) · The American Journal of Medicine · doi:10.1016/j.amjmed.2022.12.015 · Cited by 96
Self-citation
A Six-Day, Lifestyle-Based Immersion Program Mitigates Cardiovascular Risk Factors and Induces Shifts in Gut Microbiota, Specifically Lachnospiraceae, Ruminococcaceae, Faecalibacterium prausnitzii: A Pilot Study
Ahrens, A. P., Culpepper, T., Saldivar, B. N., Anton, S. D., Stoll, S., Handberg, E. M., Xu, K., Pepine, C. J., Triplett, E. W., & Aggarwal, M. (2021) · Nutrients · doi:10.3390/nu13103459 · Cited by 92
“the American College of Cardiology and the American Heart Association (ACC/AHA) guidelines [2,43].”
Background
Social Determinants of Health and Uncontrolled Blood Pressure in a National Cohort of Black and White US Adults: the REGARDS Study
Akinyelure, O. P., Jaeger, B. C., Oparil, S., Carson, A. P., Safford, M. M., Howard, G., Muntner, P., & Hardy, S. T. (2023) · Hypertension · doi:10.1161/hypertensionaha.122.20219 · Cited by 88
The 2020 International Society of Hypertension global hypertension practice guidelines - key messages and clinical considerations
Verdecchia, P., Reboldi, G., & Angeli, F. (2020) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2020.09.001 · Cited by 91
Cuff-Less Methods for Blood Pressure Telemonitoring
Bard, D. M., Joseph, J. I., & van Helmond, N. (2019) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2019.00040 · Cited by 84
Cardiovascular Effects of Flavonoids
Sánchez, M., Romero, M., Gómez‐Guzmán, M., Tamargo, J. L., Pérez‐Vizcaíno, F., & Duarte, J. (2018) · Current Medicinal Chemistry · doi:10.2174/0929867326666181220094721 · Cited by 87
Impact of community based screening for hypertension on blood pressure after two years: regression discontinuity analysis in a national cohort of older adults in China
Chen, S., Sudharsanan, N., Huang, F. Y., Liu, Y., Geldsetzer, P., & Bärnighausen, T. (2019) · BMJ · doi:10.1136/bmj.l4064 · Cited by 84
Effect of Intensive Versus Standard Blood Pressure Treatment According to Baseline Prediabetes Status: A Post Hoc Analysis of a Randomized Trial
Bress, A. P., King, J. B., Kreider, K. E., Beddhu, S., Simmons, D. L., Cheung, A. K., Zhang, Y., Doumas, M. N., Nord, J. W., Sweeney, M. E., et al. (2017) · Diabetes Care · doi:10.2337/dc17-0885 · Cited by 83
“events among participants who achieved SBP 120–124 mmHg compared with all other achieved SBP groups including 130–134, 140–144, 150–154, or 160 mmHg or higher (19).”
Background
Is early and fast blood pressure control important in hypertension management?
Volpe, M., Gallo, G., & Tocci, G. (2017) · International Journal of Cardiology · doi:10.1016/j.ijcard.2017.12.026 · Cited by 87
The Effect of Slow-Paced Breathing on Cardiovascular and Emotion Functions: A Meta-Analysis and Systematic Review
Shao, R., Man, I. S. C., & Lee, T. M. C. (2024) · Mindfulness · doi:10.1007/s12671-023-02294-2 · Cited by 97
“…reduce BP even among healthy, normotensive individuals is important, according to recent evidence that lower SBP was associated with reduced cardiovascular risks even within ranges far lower than the hypertension threshold (e.g., as low as 90 mm Hg) (Bundy et al., 2017; Whelton et al., 2020).”
Isometric Exercise Training and Arterial Hypertension: An Updated Review
Edwards, J. J., Coleman, D. A., Ritti‐Dias, R. M., Farah, B. Q., Stensel, D. J., Lucas, S. J. E., Millar, P. J., Gordon, B. D., Cornelissen, V., Smart, N. A., et al. (2024) · Sports Medicine · doi:10.1007/s40279-024-02036-x · Cited by 98
“Regardless of this diagnostic confliction, it is uniformly accepted that sBP and dBP values of 120 mmHg and 80 mmHg are optimal, and increasing pressure beyond this threshold is linearly associated with an escalated risk of CVD [9, 10].”
Background
Association of Lifestyle Factors and Antihypertensive Medication Use With Risk of All-Cause and Cause-Specific Mortality Among Adults With Hypertension in China
Lu, Q., Zhang, Y., Geng, T., YANG, K. Y., Guo, K., Min, X., He, M., Guo, H., Zhang, X., Yang, H., et al. (2022) · JAMA Network Open · doi:10.1001/jamanetworkopen.2021.46118 · Cited by 77
Blood Pressure Management in Stroke
Gorelick, P. B., Whelton, P. K., Sorond, F., & Carey, R. M. (2020) · Hypertension · doi:10.1161/hypertensionaha.120.14653 · Cited by 82
“History of stroke was permitted in the ACCORD-BP trial (Action to Control Cardiovascular Risk in Diabetes Blood Pressure; n=4733).32 Stroke—a secondary outcome—was significantly less common (hazard ratio, 0.59 [95% CI, 0.39–0.89]) in those randomized to the SBP target of <120 mm Hg compared with <140 mm Hg.”
BackgroundInfluentialSelf-citation
Longer-Term All-Cause and Cardiovascular Mortality With Intensive Blood Pressure Control
Jaeger, B. C., Bress, A. P., Bundy, J. D., Cheung, A. K., Cushman, W. C., Drawz, P. E., Johnson, K., Lewis, C. E., Oparil, S., Rocco, M. V., et al. (2022) · JAMA Cardiology · doi:10.1001/jamacardio.2022.3345 · Cited by 75
Self-citation
Changes in Blood Pressure Outcomes Among Hypertensive Individuals During the COVID-19 Pandemic: A Time Series Analysis in Three US Healthcare Organizations
Gotanda, H., Liyanage-Don, N. A., Moran, A. E., Krousel-Wood, M. A., Green, J. B., Zhang, Y., & Nuckols, T. K. (2022) · Hypertension · doi:10.1161/hypertensionaha.122.19861 · Cited by 73
“26,27 35–37 For example, one estimate suggests that a 2 mm Hg increase in systolic BP can elevate the risk of major cardiovascular disease events by 5%.”
Background
Hypertension after kidney donation: Incidence, predictors, and correlates
Sanchez, O. A., Ferrara, L. K., Rein, S., Berglund, D. M., Matas, A. J., & Ibrahim, H. N. (2018) · American Journal of Transplantation · doi:10.1111/ajt.14713 · Cited by 73
Trends of blood pressure control in the U.S. during the COVID-19 pandemic
Shah, N. P., Clare, R. M., Chiswell, K., Návar, A. M., Shah, B. R., & Peterson, E. D. (2021) · American Heart Journal · doi:10.1016/j.ahj.2021.11.017 · Cited by 72
Efficacy of an mHealth App to Support Patients’ Self-Management of Hypertension: Randomized Controlled Trial
Liu, F., Song, T., Yu, P., Deng, N., Guan, Y., Yang, Y., & Ma, Y. (2023) · Journal of Medical Internet Research · doi:10.2196/43809 · Cited by 72
“The sample size was determined through a statistical power analysis based on the change in systolic BP before and after 6 months, as it was the most critical indicator of a patient’s cardiovascular risk profile [56].”
Effect on Treatment Adherence of Distributing Essential Medicines at No Charge
Persaud, N., Bedard, M. J., Boozary, A., Glazier, R. H., Gomes, T., Hwang, S. W., Jüni, P., Law, M. R., Mamdani, M., Manns, B., et al. (2019) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2019.4472 · Cited by 69

Authors: Bundy, J. D., Li, C., Stuchlik, P., Bu, X., Kelly, T. N., Mills, K. T., He, H., Chen, J., Whelton, P. K., & He, J.
Affiliations: Tulane University (US)
Corresponding author: He, Jiang
ORCID: Bundy, Joshua D.
Li, Changwei
Bu, Xiaoqing
Kelly, Tanika N.
Mills, Katherine T.
He, Hua
Chen, Jing
Whelton, Paul K.
He, Jiang
Venue: JAMA Cardiology
Publisher: American Medical Association (AMA)
Published: 2017-07-01
Volume: 2
Issue: 7
Pages: 775
ISSN: 2380-6583 (ISSN-L)
DOI: 10.1001/jamacardio.2017.1421
PMC: PMC5710614
OpenAlex: W2618382346
Cited by: 783
References: 33
Citations by year: 2026: 59 · 2025: 102 · 2024: 96 · 2023: 99 · 2022: 65 · 2021: 95 · 2020: 80 · 2019: 78 · 2018: 73 · 2017: 35
FWCI: 56.22
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: JAMA Cardiology (publishedVersion)
Europe PMC (PubMed Central) (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Funders: National Institute of General Medical Sciences (P20GM109036)
Fogarty International Center (D43TW009107)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
Health Sciences › Nursing › Nutrition and Dietetics › Sodium Intake and Health
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Disease Prevention
Keywords: systolic blood pressure, blood pressure targets, hypertension, antihypertensive therapy, cardiovascular disease, all-cause mortality, blood pressure reduction, linear dose-response relationship, cardiovascular risk reduction, cardiovascular disease prevention, cardiovascular disease prevention and treatment
MeSH terms: Antihypertensive Agents, Blood Pressure, Cardiovascular Diseases, Humans, Hypertension, Mortality, Patient Care Planning, Systole

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Systolic Blood Pressure Reduction and Risk of Cardiovascular Disease and Mortality: A Systematic Review and Network Meta-analysis

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks